A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality

British Journal of Cancer

Volumn 98, Issue 1, 2008, Pages 206-209

  Allgood, P C ^a   Warwick, J ^a   Warren, R M L ^b   Day, N E ^c   Duffy, S W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer mortality; Case control; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 38049051460     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604123     Document Type: Article

References (16)

1. Breslow NE, Day NE (1987) Statistical Methods in Cancer Research Volume II- The Design and Analysis of Cohort Studies. Lyon: International Agency for Research on Cancer
2. Cuzick J, Edwards R, Segnan N (1997) Adjusting for non-compliance and contamination in randomized screening trials. Stat Med 16: 1017-1029
3. Duffy SW, Cuzick J, Tabar L, Vitak B, Hsiu-Hsi Chen T, Yen M-F, Smith RA (2002) Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. Appl Statist 51: 235-243
4. Elmore JG, Reisch LM, Barton MB, Barlow WE, Rolnick S, Harris EL, Herrinton LJ, Geiger AM, Beverly RK, Hart G, Yu O, Greene SM, Weiss NS, Fletcher SW (2005) Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97: 1035-1043
5. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW (2004) A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 11: 194-198
6. Gabe R, Tryggvadóttir L, Sigfússon BF, Ó lafsdóttir GH, Sigurosson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening programme on breast cancer death. Acta Radiol (in press)
7. Jonsson H, Nyström L, Törnberg S, Lenner P (2001) Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8: 152-160
8. Jonsson H, Nyström L, Törnberg S, Lundgren B, Lenner P (2003) Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gävleborg, Sweden. The Breast 12: 183-193
9. Jonsson H, Törnberg S, Nyström L, Lenner P (2000) Service screening with mammography in Sweden. Evaluation of effects from screening in age 40-49 years on the breast cancer mortality. Acta Oncol 39: 617-623
10. Mittenburg GAJ, Peeters PHM, Fracheboud J, Collette HJA (1998) Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Br J Cancer 78: 962-965
11. NHS Breast Screening Programme (2006) Annual Review 2005. NHS: Sheffield
12. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359: 909-919
13. Palli D, Rosselli del Turco M, Uiatti E, Ciatto S, Crocetti E, Paci E (1989) Time interval since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Community Health 43: 241-248
14. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen THH (2004) The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am 42: 793-806
15. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW (2003) Mammography service screening and mortality among breast cancer cases: results of 20-year follow-up before and after introduction of screening. Lancet 361: 1405-1410
16. Walter SD (2003) Mammographic screening: case-control studies. Ann Oncol 14: 1190-1192